Granisetron Transdermal Patch and Buprenorphine: Interaction Details
- Buprenorphine
- ButransBelbucaSublocade +2 more
- Granisetron Transdermal Patch
- SancusoSustolGranisol
Medically reviewed by Dr. Brian Staiger, PharmD, BCPS
Also reviewed by the HelloPharmacist Editorial Team Updated AI-assisted Details about this page
- Dr. Brian Staiger, PharmD, BCPS, is a clinical pharmacist and pharmacotherapy specialist.
- AI-assisted, written
- AI is used only to summarize verified clinical information, never the open internet.
- Editorial policy
- How we build our interaction pages →
- Our AI policy →
A close look at the Granisetron Transdermal Patch and Buprenorphine interaction:
Buprenorphine
- Butrans
- Belbuca
- Sublocade
- Buprenex
- Brixadi
Granisetron Transdermal Patch
- Sancuso
- Sustol
- Granisol
What Happens When You Take Granisetron Transdermal Patch With Buprenorphine
What can happen when they are taken together (rated Major)
An increased risk of and an increased risk of
Interaction Deep Dive
A note from Dr. Brian Staiger If you’re a patient, this deep dive may be too technical, or bore you (or both). Read the plain-language explanation →
Buprenorphine should not be combined with medications that can lengthen the . In addition, taking buprenorphine together with other agents acting on the neurotransmitter system can raise the likelihood of serotonin syndrome.
When such combined use cannot be avoided, patients should be watched for signs of serotonin syndrome, especially when therapy is started and whenever doses are changed. If serotonin syndrome is suspected, buprenorphine should be stopped.1234
The Granisetron Transdermal Patch and Buprenorphine Interaction, Explained
Buprenorphine is an used for pain or opioid dependence. Granisetron is a patch that helps prevent nausea and vomiting from chemotherapy. Taken together, both can affect your heart's electrical rhythm (called the ), and both can raise activity in the body, which in rare cases leads to .
This risk is mostly theoretical, meaning it is based on how the drugs work rather than many real-world cases. Still, warning signs include agitation, fast heartbeat, sweating, shaking, muscle twitching, and fever. Please don't stop or change either medicine on your own. Tell your pharmacist or doctor about both, and your care team can watch you closely, especially when starting or changing doses.
Mechanism: (both agents have labeled QT effects) and additive activity (5-HT3 with granisetron; buprenorphine labeled for risk). Direction is additive risk, not a PK change. Neither agent is a relevant to this interaction.
- Evidence: theoretical; onset unspecified; severity on file: major.
- Management: avoid combination where possible. If unavoidable, monitor for serotonin syndrome (mental status change, autonomic instability, neuromuscular findings), especially at initiation and dose changes, and consider and electrolyte (K, Mg) review in patients with QT risk factors.
- Discontinue buprenorphine if serotonin syndrome is suspected.
See the 4 references behind this explanation ↓
From the HelloPharmacist Pharmacy Team
AI-assisted: written with AI from this pair’s record in our interaction database, and reviewed by the HelloPharmacist pharmacy team. Written .
How we build these pages · How we use AI · Our editorial policy
Why Granisetron Transdermal Patch and Buprenorphine Interact
The likely mechanism
; additive
How to Manage the Granisetron Transdermal Patch and Buprenorphine Interaction
Keep taking both medicines as prescribed unless your prescriber tells you otherwise. Your care team may prefer to avoid this combination when another option exists. If both are needed, they may monitor you more closely, especially when either medicine is started or the dose is changed.
- Tell your pharmacist and prescriber about all medicines you take, including other nausea, pain, or antidepressant drugs.
- Know the warning signs of : agitation, confusion, rapid heartbeat, sweating, shivering, muscle twitching, diarrhea, fever.
- Get urgent medical help if these appear. Also report fainting, dizziness, or a racing or irregular heartbeat.
Management is individual — confirm any change with your pharmacist or prescriber.
Questions for Your Pharmacist
- Does my dose of Granisetron Transdermal Patch or Buprenorphine need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there another option that avoids this interaction?
Granisetron Transdermal Patch and Buprenorphine: Common Questions
How serious is the Granisetron Transdermal Patch and Buprenorphine interaction?
It is rated major. Potentially serious — often needs a change or close monitoring.
How is the Granisetron Transdermal Patch and Buprenorphine interaction managed?
Keep taking both medicines as prescribed unless your prescriber tells you otherwise. Your care team may prefer to avoid this combination when another option exists. If both are needed, they may monitor you more closely, especially when either medicine is started or the dose is changed. Tell your pharmacist and prescriber about all medicines you take, including other nausea, pain, or antidepressant… Management is individual — always follow your own care team's guidance.
How quickly could this interaction happen?
The documented onset is "unspecified". The timing of this interaction is not well characterized.
How strong is the evidence for this interaction?
The evidence is graded "theoretical". Expected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study.
Ask About the Granisetron Transdermal Patch and Buprenorphine Interaction
Ask in your own words about taking Granisetron Transdermal Patch and Buprenorphine together. The answer comes from this page’s interaction record and both drugs’ own information.
This box answers questions about this one combination only. For anything else about either drug, open its drug information page or ask a pharmacist.
AI answers from this page’s record and both drugs’ information, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.
References (4)
- Product Information: BELBUCA(TM) buccal film, buprenorpine buccal film. Endo Pharmaceuticals Inc. (per manufacturer), Malvern, PA, 2015.
- Product Information: BUPRENEX(R) intravenous injection, intramuscular injection, buprenorphine HCl intravenous injection, intramuscular injection. Indivior Inc. (per DailyMed), Richmond, VA, 2016. DailyMed
- Product Information: BUTRANS(R) transdermal system patch, buprenorphine transdermal system patch. Purdue Pharma L.P. (per FDA), Stamford, CT, 2016. DailyMed
- Product Information: BRIXADI(TM) subcutaneous extended-release injection, buprenorphine subcutaneous extended-release injection. Braeburn Inc (per FDA), Plymouth Meeting, PA, 2023. DailyMed
Other Serious Interactions of Granisetron Transdermal Patch and Buprenorphine
Also serious with Buprenorphine
- DronedaroneContraindicated
- FluconazoleContraindicated
- IsocarboxazidContraindicated
- KetoconazoleContraindicated
Also serious with Granisetron Transdermal Patch
These Medications Also Interact With Supplements
Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:
With Buprenorphine
- GrapefruitMajor
- St. John's WortMajor
- Activated CharcoalMajor
- KavaMajor
- WineMajor
- 1,4-butanediolMajor
- BeerMajor
- Gamma-hydroxybutyrate (GHB)Major
- + 210 more
Check everything you take with our drug–supplement interaction checker.
Still Have Questions About This Combination?
Every question gets a real answer from a licensed pharmacist — free, as soon as they can.
About This Library
Built in-house, documented one interaction at a time. Our interaction database is not a complete list of every known interaction: a combination that isn't listed here hasn't been documented by us yet, which never means it's safe. Checking everything you take at once? Ask your pharmacist to review your full medication list. How we build and review it →
What Each Rating Means
Severity Levels
- Contraindicated These should generally not be used together.
- Major Potentially serious — often needs a change or close monitoring. This interaction.
- Moderate Can be significant — usually manageable with monitoring.
- Minor Usually limited clinical impact.
Evidence Grades
- EstablishedWell documented — supported by controlled studies or strong clinical data.
- ProbableGood supporting evidence, though not definitively proven.
- SuspectedSome evidence suggests this interaction, but it is not well established.
- PossibleLimited or conflicting evidence; the interaction may occur.
- TheoreticalExpected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study. This interaction.
How Soon It Shows
- RapidEffects can appear quickly, often within about 24 hours of combining the drugs.
- DelayedEffects tend to build up gradually over days to weeks.
- UnspecifiedThe timing of this interaction is not well characterized. This interaction.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.